Claris obtains approval from Russia to market two generic drugs

Claris Lifesciences has told on Thursday that it has obtained approval from the Russian Ministry of Health to market two intravenous injections, Fluconazole IV and Levofloxacin IV, used to cure different fungal and bacterial diseases, respectively, in Russia.